Increased expression of soluble decoy receptor 3 in acutely inflamed intestinal epithelia

Sunghee Kim1, Anastasia Fotiadu, Vassiliki Kotoula

  • 1Department of Biological Sciences, University of Alabama, Rm 280 Nott Hall, Tuscaloosa, AL 35487, USA. skim@bsc.as.ua.edu

Insights

Decoy receptor 3 (DcR3) release increases in human intestinal cells stimulated by lipopolysaccharide (LPS) via Toll-like receptor 4 (TLR-4) activation. This suggests DcR3 plays a role in intestinal inflammation.

Area of Science:

  • Immunology
  • Gastroenterology
  • Molecular Biology

Background:

  • Decoy receptor 3 (DcR3) is a soluble receptor inhibiting apoptosis induced by TNF-family cytokines.
  • Regulation of DcR3 expression is crucial for cellular and tissue homeostasis.
  • Understanding DcR3's role in inflammatory conditions is of significant interest.

Purpose of the Study:

  • To investigate the regulation of DcR3 release in human intestinal epithelial cells (IECs).
  • To explore the signaling pathways involved in DcR3 induction by lipopolysaccharide (LPS).
  • To assess DcR3 expression in acute appendicitis.

Main Methods:

  • Cultured human IEC lines (SW480, SW620, HT29) were stimulated with LPS.
  • Toll-like receptor 4 (TLR-4) expression was assessed.
  • MAPK (ERK1/2, JNK) and NF-kappaB activation pathways were analyzed.
  • DcR3 expression in appendix tissues from appendicitis patients was examined.

Main Results:

  • IEC lines selectively increased DcR3 release upon LPS stimulation.
  • All tested IEC lines expressed TLR-4.
  • LPS-induced DcR3 release involved MAPK and NF-kappaB activation.
  • Increased DcR3 expression was observed in appendix epithelia of appendicitis patients.

Conclusions:

  • Human intestinal epithelial cells increase DcR3 release in response to LPS, mediated by TLR-4, MAPK, and NF-kappaB.
  • DcR3 may play a significant role in the human intestinal epithelium during endotoxin-induced acute inflammatory processes.
  • These findings highlight DcR3's potential involvement in inflammatory bowel diseases.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.